Capital One Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$2M Sell
7,000
-210
-3% -$54K 1.42% 23
2021
Q4
$1.99M Hold
7,210
0.24% 55
2021
Q3
$1.67M Hold
7,210
0.21% 55
2021
Q2
$1.66M Hold
7,210
0.2% 53
2021
Q1
$1.35M Sell
7,210
-283
-4% -$55.4K 0.17% 53
2020
Q4
$1.26M Sell
7,493
-575
-7% -$85.9K 0.17% 61
2020
Q3
$1.19M Hold
8,068
0.15% 77
2020
Q2
$1.32M Sell
8,068
-313
-4% -$48K 0.18% 86
2020
Q1
$1.16M Buy
+8,381
New +$1.15M 0.19% 97

Other funds holding LLY

Capital One Financial's LLY Position: Q1 2022 in Review

Capital One Financial reduced its Eli Lilly (LLY) stake by 2.9% in Q1 2022, selling an estimated $54K and leaving 7,000 shares worth $2M. The position accounts for 1.42% of the portfolio, ranked #23.

Capital One Financial first reported a position in LLY in Q1 2020 and has held it in 9 quarters since. 2,343 funds tracked by Wall St. Rank hold LLY as of Q1 2022.

  • Capital One Financial held 7,000 shares of Eli Lilly worth $2M as of Q1 2022.
  • Capital One Financial sold 210 Eli Lilly shares in Q1 2022, an estimated $54K.
  • Eli Lilly made up 1.42% of Capital One Financial's portfolio in Q1 2022, its #23 holding.
  • Capital One Financial first reported a position in Eli Lilly in Q1 2020 and has held it in 9 quarters since.
  • 2,343 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2022.

Based on Capital One Financial's 13F filing for Q1 2022, filed 13 Apr 2022.